Pharmaceutical logistics and clinical research: the industry's main moves in March

The pharmaceutical industry and the clinical research sector are constantly evolving. Technological advances, geopolitical changes and new investments are directly impacting the way medicines are produced, transported and distributed around the world.

However, in recent weeks (17/03), a number of events have attracted attention for showing how the global health chain is changing, especially when it comes to pharmaceutical logistics, clinical research and specialized supply chain.

Below, we've put together some of the main highlights to help you understand the direction of the sector.

Medicines air routes hit by tensions in the Middle East

Geopolitical conflicts in the Middle East have begun to impact air routes used for the international transportation of medicines and pharmaceutical products.

According to a Reuters report, some airlines have started to avoid certain regions of the area due to operational risks. This could lead to the rerouting of flights and an increase in transportation times for sensitive cargo.

This type of change can especially affect medicines that require temperature-controlled transportation, such as cancer treatments and biological products.

Read the full article

Situations like this reinforce the importance of resilient and planned logistics chains, capable of reacting quickly to changes in the international scenario.

Technology gains ground in clinical trial logistics

At the same time, digital transformation continues to advance within pharmaceutical logistics and clinical research.

Companies in the sector are expanding their use of technologies such as real-time monitoring, data analysis and logistical forecasting systems to monitor the transportation of medicines and materials used in clinical studies.

For this reason, these solutions provide greater visibility over the entire supply chain, helping to predict possible delays, optimize routes and reduce operational risks during the conduct of studies.

More information on innovation initiatives in the area can be found on the portal Brazil's clinical trials officer.

However, with the growth in the number of clinical trials around the world, the trend is for digital tools to become increasingly essential to ensure operational efficiency and safety.

Investments reinforce the expansion of the pharmaceutical industry

Another important movement comes from increased investment in pharmaceutical production and supply chain.

Pharmaceutical company Eli Lilly recently announced an investment of approximately US$ 3 billion to expand its production and logistics capacity in China. Especially focused on the supply of diabetes and obesity drugs.

For this reason, the initiative seeks to meet the growing global demand for treatments in this category, which has shown strong growth in recent years.

See the full story.

However, this type of investment shows how logistics infrastructure and productive capacity are becoming strategic factors for the pharmaceutical sector.

Logistics as a strategic element in the health industry

All these movements show that pharmaceutical logistics is no longer just an operational step, but a strategic component within the healthcare industry.

Whether it's to ensure the safe transportation of medicines, support clinical trials or enable the global distribution of treatments, the efficiency of the logistics chain is essential to the functioning of the entire pharmaceutical ecosystem.

For this reason, companies specializing in supply chain for the pharmaceutical industry and clinical research play a key role in this scenario, connecting suppliers, research centers, hospitals and patients.

FIC offers complete supply chain solutions for the global health sector. This includes the supply of medicines, qualified storage, specialized transport and logistics management for clinical projects.

Find out more about our solutions.